BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yamaguchi H, Kitayama J, Ishigami H, Kazama S, Nozawa H, Kawai K, Hata K, Kiyomatsu T, Tanaka T, Tanaka J, Nishikawa T, Otani K, Yasuda K, Ishihara S, Sunami E, Watanabe T. Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes. World J Gastrointest Oncol 2015; 7(11): 285-291 [PMID: 26600928 DOI: 10.4251/wjgo.v7.i11.285]
URL: https://www.wjgnet.com/1007-9327/full/v7/i11/285.htm
Number Citing Articles
1
Manuela Robella, Michele De Simone, Paola Berchialla, Monica Argenziano, Alice Borsano, Shoeb Ansari, Ornella Abollino, Eleonora Ficiarà, Armando Cinquegrana, Roberta Cavalli, Marco Vaira. A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal CarcinomatosisCancers 2021; 13(5): 1060 doi: 10.3390/cancers13051060
2
Hideyuki Ohzawa, Yuki Kimura, Akira Saito, Hironori Yamaguchi, Hideyo Miyato, Yasunaru Sakuma, Hisanaga Horie, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric CancerAnnals of Surgical Oncology 2020; 27(13): 5057 doi: 10.1245/s10434-020-09007-2
3
Minlu Huang, Xinjie Ma, Hongpeng Shi, Lei Hu, Zhiyuan Fan, Li Pang, Fan Zhu, Xiao Yang, Wei Xu, Binya Liu, Zhenggang Zhu, Chen Li. FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancerOncotarget 2017; 8(43): 74479 doi: 10.18632/oncotarget.20157
4
Roman Yarema, Мyron Оhorchak, Petro Hyrya, Yuriy Kovalchuk, Victor Safiyan, Ivan Karelin, Severyn Ferneza, Markiyan Fetsych, Myron Matusyak, Yuriy Oliynyk, Тaras Fetsych. Gastric cancer with peritoneal metastases: Efficiency of standard treatment methodsWorld Journal of Gastrointestinal Oncology 2020; 12(5): 569-581 doi: 10.4251/wjgo.v12.i5.569
5
Amir Parray, Vikas Gupta, Vikram A. Chaudhari, Shailesh V. Shrikhande, Manish S. Bhandare. Role of intraperitoneal chemotherapy in gastric cancerSurgery in Practice and Science 2021; 4: 100025 doi: 10.1016/j.sipas.2020.100025
6
Akira Saito, Joji Kitayama, Ryozo Nagai, Kenichi Aizawa. Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: ReviewPharmaceutics 2023; 15(6): 1664 doi: 10.3390/pharmaceutics15061664
7
Y. Hao, Y. Liu, H. Ishibashi, S. Wakama, E. Nishino, Y. Yonemura. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasisEuropean Journal of Surgical Oncology 2019; 45(8): 1493 doi: 10.1016/j.ejso.2019.03.011
8
Amy Y. Li, Shaina Sedighim, Fatemeh Tajik, Aaqil M. Khan, Vinodh K. Radhakrishnan, Farshid Dayyani, Maheswari Senthil. Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal DiseaseJournal of Gastrointestinal Cancer 2024;  doi: 10.1007/s12029-023-00994-5
9
Lin Hu, Hong-Lang Li, Wei-Feng Li, Jun-Min Chen, Jian-Tao Yang, Jun-Jing Gu, Lin Xin. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinomaWorld Journal of Gastroenterology 2017; 23(20): 3721-3729 doi: 10.3748/wjg.v23.i20.3721
10
Pralhad Wangikar, M. V. S. Sandhya, Pradhnya Choudhari. Exploring Drug Delivery to the Peritoneum2023; : 217 doi: 10.1007/978-3-031-31694-4_10
11
Zhen Wang, Jun-qiang Chen, Jin-lu Liu, Lei Tian. Issues on peritoneal metastasis of gastric cancer: an updateWorld Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1761-y
12
Koki Nakanishi, Mitsuro Kanda, Shinichi Umeda, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Suguru Yamada, Yasuhiro Kodera. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancerGastric Cancer 2019; 22(6): 1143 doi: 10.1007/s10120-019-00967-3
13
Daisuke Kobayashi, Yasuhiro Kodera. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasisGastric Cancer 2017; 20(S1): 111 doi: 10.1007/s10120-016-0662-9
14
Mitsuro Kanda, Dai Shimizu, Haruyoshi Tanaka, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Naoki Iwata, Yukiko Niwa, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Kenta Murotani, Michitaka Fujiwara, Yasuhiro Kodera. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric CancerAnnals of Surgery 2018; 267(3): 495 doi: 10.1097/SLA.0000000000002096
15
Manuela Robella, Marco Vaira, Monica Argenziano, Rita Spagnolo, Roberta Cavalli, Alice Borsano, Sergio Gentilli, Michele De Simone. Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx®) as Pressurized Intraperitoneal Aerosol ChemotherapyFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00669
16
Maheswari Senthil, Farshid Dayyani. Role of Iterative Normothermic Intraperitoneal Paclitaxel Combined with Systemic Chemotherapy in the Management of Gastric Peritoneal CarcinomatosisAnnals of Surgical Oncology 2024; 31(2): 694 doi: 10.1245/s10434-023-14258-w
17
Hanqing Qian, Keyang Qian, Juan Cai, Yan Yang, Lijing Zhu, Baorui Liu. Therapy for Gastric Cancer with Peritoneal Metastasis Using Injectable Albumin Hydrogel Hybridized with Paclitaxel-Loaded Red Blood Cell Membrane NanoparticlesACS Biomaterials Science & Engineering 2019; 5(2): 1100 doi: 10.1021/acsbiomaterials.8b01557
18
Shunsuke Akagi, Hidenori Ando, Kenji Fujita, Taro Shimizu, Yu Ishima, Kenji Tajima, Tokuo Matsushima, Takatomo Kusano, Tatsuhiro Ishida. Therapeutic efficacy of a paclitaxel-loaded nanofibrillated bacterial cellulose (PTX/NFBC) formulation in a peritoneally disseminated gastric cancer xenograft modelInternational Journal of Biological Macromolecules 2021; 174: 494 doi: 10.1016/j.ijbiomac.2021.01.201
19
Beatrice J. Sun, Byrne Lee. Review of Regional Therapies for Gastric Cancer with Peritoneal MetastasesCancers 2022; 14(3): 570 doi: 10.3390/cancers14030570
20
Manuela Robella, Paola Berchialla, Alice Borsano, Armando Cinquegrana, Alba Ilari Civit, Michele De Simone, Marco Vaira. Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal MetastasesInternational Journal of Environmental Research and Public Health 2021; 18(11): 5656 doi: 10.3390/ijerph18115656
21
Maheswari Senthil, Farshid Dayyani. Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trialBMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10680-1
22
Xin Zhang, Hejing Huang, Dejun Yang, Peng Wang, Xin Huang, Zunqi Hu, Yu Zhang, Ronglin Yan, Zhenxin Zhu, Qingping Cai. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched AnalysisTechnology in Cancer Research & Treatment 2021; 20: 153303382110363 doi: 10.1177/15330338211036310
23
Tomoko Tachibana, Yukie Yoshii, Hiroki Matsumoto, Ming-Rong Zhang, Kotaro Nagatsu, Fukiko Hihara, Chika Igarashi, Aya Sugyo, AtsushiB Tsuji, Tatsuya Higashi. Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with 64Cu-labeled cetuximab against peritoneal dissemination of gastric cancer in a mouse modelJournal of Cancer Research and Therapeutics 2022; 18(4): 907 doi: 10.4103/jcrt.JCRT_124_20
24
Hironori Yamaguchi, Yumiko Satoh, Hironori Ishigami, Makiko Kurihara, Yutaka Yatomi, Joji Kitayama. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal MetastasisAnnals of Surgical Oncology 2017; 24(11): 3345 doi: 10.1245/s10434-017-5997-x